Engerix-B
Selected indexed studies
- Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy. (Vaccine, 2020) [PMID:32741674]
- Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. (Drugs, 2003) [PMID:12699402]
- Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. (Postgrad Med J, 1987) [PMID:3317357]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Adult immunization. (2022) pubmed
- Vaccines for travelers. (2018) pubmed
- Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy. (2020) pubmed
- Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. (2003) pubmed
- Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. (1987) pubmed
- Hepatitis B Vaccine. (2006) pubmed
- Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. (2020) pubmed
- Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease. (2023) pubmed
- Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial. (2016) pubmed
- A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh. (2021) pubmed